Recent Insights
Newsletter
January 20, 2026
Review key Q3 2025 SALT updates and uncover practical insights to navigate compliance, planning and alignment with shifting state and local tax policies.
28:06
Speakers: Brooks E. Nelson, Sarah McGregor, Nelson C. Yates II
Learn how middle-market CFOs can navigate international tax, transfer pricing, and global compliance to manage risk and support growth in 2026.
Article
January 8, 2026
Explore our exit stage guide for life science companies and uncover key strategies for successfully navigating the final phase of the startup lifecycle.
Article
December 18, 2025
Explore our guide for multinational businesses navigating OBBBA international tax changes and their implications for 2025 filing and 2026 planning.
Newsletter
December 17, 2025
Explore key updates from the December 2025 tax policy review, including major 2025 milestones, expectations for 2026 and new tax reform guidance.
Article
December 17, 2025
The clinical stage of drug development involves navigating the phases of clinical trials and fundraising to support them. Explore our guide for startups.
26:26
Speakers: Jason Callaham, Joseph Hennessee
Understand targeted populations in NMTC deals and learn how nonprofits, businesses, and investors can leverage tax credits for community projects.
Case Study
December 9, 2025
See how Cherry Bekaert's SFS team secured allocation to help the Food Bank of Central & Eastern North Carolina's Wilmington branch add capacity.
Article
July 25, 2025
Updated: December 8, 2025
Starting in the 2025 tax year, the Section 174 repeal lets businesses immediately deduct domestic R&E expenditures. Explore what else is changing.
33:49
Speakers: Sarah McGregor, Brooks E. Nelson, Kasey Pittman
Explore 2025 tax reform changes, IRS operations during shutdowns, and economic trends shaping planning decisions for businesses and individuals.